Observational studyJournal of diabetes research2025

Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors Improve Renal Resistive Index in Patients With Type 2 Diabetes: A 26-Week Prospective Observational Real-Life Study.

Alfredo Vozza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.